{"url_path":"/sec/xeri/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 Unregistered Sales of Equity Securities**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1481504/0001477932-26-003234-index.html","accession_number":"0001477932-26-003234","cik":"0001481504","ticker":"XERI","issuer_name":"XERIANT, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1481504/0001477932-26-003234-index.html","primary_entity_key":"0001481504","primary_entity_name":"XERIANT, INC."},"word_count":128,"has_tables":true,"body_markdown":"**Item 2. Unregistered Sales of Equity Securities**\n\n \n\nDuring the nine-month period ended March 31, 2026, the Company issued 26,700,855 shares for various services, 102,654,000 shares from conversion of Series A Preferred stock, 59,510,000 shares for conversion of principal and accrued interest, and 30,000,000 shares issued in connection with the Auctus Settlement. The Company believes that the issuance of the securities was exempt from registration under the Securities Act of 1933, as amended, in reliance on Section 4(2) of the Securities Act as a transaction by an issuer not involving any public offering and based on the fact that such securities were issued for services to sophisticated or accredited investors and persons who are thoroughly familiar with the Company’s proposed business by virtue of their affiliation with the Company."}